Ponoi Management, LLC is 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 8 open-market trades across 2 companies since 2019, most recently 2022-06-09.
CIK 0001720702
8 open-market purchases totalling $7.7M since 2019, never a sale. Across 8 scored buys the stock is up 30.1% at ninety days, and 23.9 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 75% | 88% | 75% |
| Avg Move | +7.2% | +17.6% | +30.1% |
| Alpha | +6.1% | +18.1% | +23.9% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGM | BUY | 2022-06-09 | 2022-06-13 | $13.50 | $438K | +16.0% | +22.4% | +27.6% |
| NGM | BUY | 2022-05-26 | 2022-05-31 | $13.49 | $309K | -8.1% | -8.7% | +5.8% |
| NGM | BUY | 2022-05-24 | 2022-05-26 | $13.41 | $820K | +1.1% | +7.8% | +19.5% |
| RAPT | BUY | 2022-05-23 | 2022-05-25 | $12.19 | $11K | +20.4% | +36.9% | +88.2% |
| NGM | BUY | 2022-05-09 | 2022-05-11 | $10.95 | $1.3M | +28.7% | +20.8% | +52.1% |
| NGM | BUY | 2020-03-19 | 2020-03-23 | $11.68 | $3.4M | +2.9% | +29.2% | +84.0% |
| NGM | BUY | 2019-07-24 | 2019-07-26 | $13.49 | $1.2M | +1.7% | +29.0% | -5.8% |
| NGM | BUY | 2019-07-15 | 2019-07-17 | $13.69 | $222K | -4.8% | +3.5% | -30.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.